Found 55 matching trials
Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma PHASE2 This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Show More Location
Harbin Medical University Cancer Hospital
Learn More & Join Trial
Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC NA The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Radiation Oncology Department, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects PHASE2 Evaluate the safety, tolerability, and objective response rate (ORR) of SHR...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung Cancer PHASE2 This randomized phase II exploratory clinical study aims to evaluate the ef...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial of SHR-1701 in Subjects With Advanced Solid Tumors PHASE1 This is a dose-escalation and dose-expansion Phase 1 trial to evaluate the ...
Show More Location
Icon Cancer Care Centre
Learn More & Join Trial
SHR-1701 in Patients With Recurrent/Metastatic Scchn PHASE2 This is an open label, single-arm, multi-center, phase II study of SHR-1701...
Show More Location
Tumor Hospital of the Chinese Academy of Medical Sciences
Learn More & Join Trial
SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis PHASE2 This study is a prospective, randomized, two-cohort trial designed to evalu...
Show More Location
Changhai Hospital
Learn More & Join Trial
PD1/TGFฮฒ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer PHASE2 Immunotherapy combined with chemotherapy has become the standard first-line...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer PHASE2 This study is a randomized, open-label, double-cohort, national multi-cente...
Show More Location
Multiple Locations
Learn More & Join Trial